[1]ZHAO XY, ZHANG X, WANG TL, et al.Clinical and pathological features of patients with congenital hepatic fibrosis[J].J Clin Hepatol, 2010, 26 (2) :191-193 (in Chinese) 赵新颜, 张新, 王泰龄, 等.先天性肝纤维化14例临床病理特点[J].临床肝胆病杂志, 2010, 26 (2) :191-193.
|
[2]WARD CJ, YUAN D, MASYUK TV, et al.Cellular and subcellular localization of the ARPKD protein;fibrocystin is expressed on primary cilia[J].Hum Mol Genet, 2003, 12 (20) :2703-2710.
|
[3]ZHANG MZ, MAI W, LI C, et al.PKHD1 protein encoded by the gene for autosomal recessive polycystic kidney disease associates with basal bodies and primary cilia in renal epithelial cells[J].Proc Natl Acad Sci U S A, 2004, 101 (8) :2311-2316.
|
[4]ONUCHIC LF, FURU L, NAGASAWA Y, et al.PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats[J].Am J Hum Genet, 2002, 70 (5) :1305-1317.
|
[5]WARD CJ, HOGAN MC, ROSSETTI S, et al.The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein[J].Nat Genet, 2002, 30 (3) :259-269.
|
[6]GUNAY-AYGUN M, TUCHMAN M, FONT-MONTGOMERYE, et al.PKHD1 sequence variations in 78 children and adults with autosomal recessive polycystic kidney disease and congenital hepatic fibrosis[J].Mol Genet Metab, 2010, 99 (2) :160-173.
|
[7]FENG MS, MA WB, TANG SH, et al.Pathogenesis of congenital hepatic fibrosis and current status of its diagnosis and treatment[J].J Clin Hepatol, 2017, 33 (3) :553-557. (in Chinese) 冯茂森, 马文斌, 汤善宏, 等.先天性肝纤维化的发病机制及诊治现状[J].临床肝胆病杂志, 2017, 33 (3) :553-557.
|
[8]WU X, DU XR, DING JF, et al.Clinical features of congenital hepatic fibrosis in children[J].J Clin Pediatr, 2016, 34 (6) :444-448. (in Chinese) 吴欣, 杜霄壤, 丁金芳, 等.儿童先天性肝纤维化的临床特点[J].临床儿科杂志, 2016, 34 (6) :444-448.
|
[9]MEKAHLI D, STRALEN KJ, BONTHUIS M, et al.Kidney versus combined kidney and liver transplantation in young people with autosomal recessive polycystic kidney disease:Data from the European Society for Pediatric Nephrology/European Renal Association-European Dialysis and Transplant (ESPN/ERA-EDTA) [J].Am JKidney Dis, 2016, 68 (5) :782-788.
|
[10]CHENG ZL, WANG YM.Research progress of Ig G4 associated cholangitis[J].Chin Hepatol, 2015, 20 (9) :721-722, 732. (in Chinese) 程智玲, 王宇明.Ig G4相关性胆管炎的研究进展[J].肝脏, 2015, 20 (9) :721-722, 732.
|
[11]ZHU XF, ZOU DW.Research progress of Ig G4 related digestive diseases[J].Chin J Pancreatol, 2014, 14 (1) :57-61. (in Chinese) 朱晓斐, 邹多武.Ig G4相关性消化疾病的研究进展[J].中华胰腺病杂志, 2014, 14 (1) :57-61.
|
[12]NAKANUMA Y, ZEN Y.Pathology and immunopathology of immunoglobulin G4-related sclerosing cholangitis:The latest addition to the sclerosing cholangitis family[J].Hepatol Res, 2007, 37 (Suppl3) :s478-s486.
|
[13]ASANO J, WATANABE T, OGUCHI T, et al.Association between immunoglobulin G4-related disease and malignancy within 12 years after diagnosis:An analysis after longterm followup[J].J Rheumatol, 2015, 42 (11) :2135-2142.
|
[14]LOCATELLI L, CADAMURO M, SPIRLC, et al.Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis[J].Hepatology, 2016, 63 (3) :965-982.
|
[15]TANG RJ, LIU ZW, SU HB, et al.The clinical features analysis of48 cases of congenital hepatic fibrosis[J].Chin Hepatol, 2013, 18 (2) :75-76. (in Chinese) 汤汝佳, 刘振文, 苏海滨, 等.先天性肝纤维化48例临床特点分析[J].肝脏, 2013, 18 (2) :75-76.
|